After extensive research, trial/error, and modifications, a truly molecular-only based phenotypic antibiotic susceptibility research assay was developed.
Mokan Labs, LLC became the first laboratory in the United States to implement use of this RUO assay in 2021. Since that time, they have processed over 20,000 results with the use of this innovative technology and diagnostics.
Evolve Consortium launched in 2025 after repeated requests from laboratories for this RUO assay. Supporting laboratories with the needed technology and reporting software for molecular AST is transforming the diagnostics space.
Open today | 09:00 am – 05:00 pm |
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.